Renal interstitial fibrosis and urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi).
about
Chinese herbs containing aristolochic acid associated with renal failure and urothelial carcinoma: a review from epidemiologic observations to causal inferenceLynch syndrome and exposure to aristolochic acid in upper-tract urothelial carcinoma: its clinical impact?End-stage renal disease in Taiwan: a case-control studyResponse of Bone Resorption Markers to Aristolochia longa Intake by Algerian Breast Cancer Postmenopausal Women.Detoxification of aristolochic acid I by O-demethylation: less nephrotoxicity and genotoxicity of aristolochic acid Ia in rodents.Urinary d-lactate levels reflect renal function in aristolochic acid-induced nephropathy in mice.Balkan endemic nephropathy-current status and future perspectives.Drug bioactivation, covalent binding to target proteins and toxicity relevance.3,4- and 3,5-Disubstituted 2-Pyridones Using an Intermolecular Cycloaddition / Cycloreversion Strategy: Toward the Synthesis of Aristopyridinone A.[Survey of toxicological aspects of herbal medicine used by a herbalist in Fes, Morocco].Prevalence of dietary supplement use in healthy pre-school Chinese children in Australia and China.A brief study of toxic effects of some medicinal herbs on kidneyDrug interactions with phytotherapeutics in oncology.Alpha-Actinin-4 is a Possible Target Protein for Aristolochic Acid I in Human Kidney Cells In Vitro.p-Benzoquinone initiates non-invasive urothelial cancer through aberrant tyrosine phosphorylation of EGFR, MAP kinase activation and cell cycle deregulation: Prevention by vitamin C.Traditional Chinese Medicine (TCM) and Herbal Hepatotoxicity: RUCAM and the Role of Novel Diagnostic Biomarkers Such as MicroRNAs.In silico toxicological screening of natural products.Assessing the recovery from prerenal and renal acute kidney injury after treatment with single herbal medicine via activity of the biomarkers HMGB1, NGAL and KIM-1 in kidney proximal tubular cells treated by cisplatin with different doses and exposu
P2860
Q26995515-CEE0A421-861E-402F-A871-2D0F43516009Q28067471-0F79B27B-DBE6-40B4-8FBC-3BBDE95F256AQ28395995-863151C7-071C-48BA-AA8A-8E3E00B24F14Q33616333-DA523AF3-C567-49B6-BCD0-F6BC2A04FCE8Q34481483-187F8DF5-5794-4074-8C02-847F8D606DDDQ34647287-BD44FB02-80FF-48FE-B568-EE2400BEB323Q35452465-5AD7E247-2B11-4A0A-B180-C64BCB7F3C46Q36061821-06385627-C4AD-481E-85C8-A744EC8C70A5Q36238058-5FA58781-2CE3-40AB-B74C-E1E0104FB6E3Q36895163-680E7F4A-4693-449B-B9F6-6D9BBF6874B8Q37617752-D4303287-A744-4C76-84A3-F902D13F962FQ38074664-FF0E4D2E-41AD-4B77-9909-DAD567A09CA4Q38175476-068B28D7-6D57-4E36-8DB9-1DABD0045A28Q38778100-7CBA37F8-32E5-40DF-AA7B-C590FFCEC4BEQ41678957-88A90EF1-2F05-41C6-80B9-A8AD94CA5BB0Q41747844-7D920F2B-B027-4CE7-97D6-0EC19E8A8128Q43215869-D3A293A6-8A48-41C7-BFD2-DDA4DEBB8161Q47105556-DC67A177-ACC6-47D3-832C-964B29322304
P2860
Renal interstitial fibrosis and urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi).
description
2002 nî lūn-bûn
@nan
2002 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Renal interstitial fibrosis an ...... e herb (Aristolochia fangchi).
@ast
Renal interstitial fibrosis an ...... e herb (Aristolochia fangchi).
@en
type
label
Renal interstitial fibrosis an ...... e herb (Aristolochia fangchi).
@ast
Renal interstitial fibrosis an ...... e herb (Aristolochia fangchi).
@en
prefLabel
Renal interstitial fibrosis an ...... e herb (Aristolochia fangchi).
@ast
Renal interstitial fibrosis an ...... e herb (Aristolochia fangchi).
@en
P1433
P1476
Renal interstitial fibrosis an ...... e herb (Aristolochia fangchi).
@en
P2093
Nortier JL
Vanherweghem JL
P304
P356
10.1016/S0300-483X(02)00486-9
P407
P478
P577
2002-12-01T00:00:00Z